Company Snapshot


Change Company Name
 
Aurobindo Pharma Ltd
Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
524804
NSE Symbol
AUROPHARMA
P/E
37.63
ISIN Demat
INE406A01037
Div & Yield %
0.22
EPS
47.76
Book Value
406.24
Market Cap (Rs Cr.)
103,395.41
Face Value
1
Stock Price Details
Last Price (₹) 1,771.30
Change +8.70 (0.49%)
Best Buy (₹) 0
Best Sell (₹) 0
Today's Range 1,771.30 - 1,805.00
52-Week Range 1,106.25 - 1,805.00
Beta (1 Year) 0.40
Chart
1 Day | 5 Day | 3 Month | 1 Year | 5 Year
Index Details
BSE 500, BSE 200, BSE HC, BSE DOLLEX, BSE Midcap
Corporate Announcements
Aurobindo Pharma consolidated net profit rises 32.72% in the September 2026 quarter
Board of Aurobindo Pharma recommends interim dividend
Aurobindo Pharma Ltd up for five straight sessions
Aurobindo Pharma Ltd up for third consecutive session
Aurobindo Pharma to announce Quarterly Result
Aurobindo Pharma receives USFDA approval for Beclomethasone Dipropionate HFA Inhalation Aerosol
Aurobindo Pharma receives US FDA nod for metered Beclomethasone Dipropionate aerosol
Aurobindo Pharma Ltd soars 1.19%
Aurobindo Pharma Ltd spurts 3.36%, gains for fifth straight session
Aurobindo Pharma's Unit-VI completes USFDA inspection
Corporate Details
Incorporation Year : 1986
Chairman : M R Kumar
Ownership Group : Indian Private
Sector : Pharmaceuticals
Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln
Registered Office :

Aurobindo Pharma Ltd
Plot No 2 Maitrivihar,
Behind Maithri Vanam Ameerpet,
Hyderabad,
Telangana - 500038,
Phone : 91-40-23736370,
Fax : 91-40-23747340
E-Mail : cs@aurobindo.com; investorgrievances@aurobindo.com
URL : http://www.aurobindo.com
Investor Returns
Period Date Price(₹) Returns (%)
1Week 30-Oct-2026 1,677.80 +7.10
1Month 06-Oct-2026 1,690.00 +6.33
3Month 06-Aug-2026 1,589.50 +13.05
6Month 06-May-2026 1,483.40 +21.14
1Year 06-Nov-2025 1,140.55 +57.56
Mutual Funds Holding
Scheme Name % Holding Market Value (₹.Cr)
HDFC Mid Cap Fund 2.19 2231.24
Quant ELSS Tax Saver Fund 8.75 1118.51
SBI Large & Midcap Fund 1.94 785.84
Quant Mid Cap Fund 10.14 757.94
Quant Multi Cap Fund 9.94 715.82
Peer Groups : Pharmaceuticals - Indian - Bulk Drugs & Formln
Company Last Price(₹) Change(%) 52Week High(₹) 52Week Low(₹) Market Cap(₹)
Sun Pharmaceutical Industries Ltd 1,860.00 +1.90 2,047.55 1,583.60 446,276.30
Laurus Labs Ltd 2,335.00 -0.43 2,442.00 913.35 126,162.90
Zydus Lifesciences Ltd 1,195.00 -0.12 1,266.15 835.85 119,201.71
Dr Reddys Laboratories Ltd 1,371.20 +0.76 1,414.40 1,080.05 114,532.44
Cipla Ltd 1,409.00 +0.52 1,539.25 1,165.55 113,828.97

Mail Us

Exclusive E-mail Id for redressal of investor grievances

jyotiinvestorgrievance@rediffmail.com
BSE Delayed data sourced at 5 mins : www.bseindia.com | NSE Delayed data sourced at 15 mins : www.nseindia.com
ATTENTION INVESTORS:
"Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day.      |      " KYC is one time excercise while dealing in securities markets-once KYC is done through a SEBI registered intermediary (broker,DP,Mutual Fund etc),you need not undergo the same process again when you approach another intermediary."      |      "Contents which are exclusively for Non-Broking Products/Services, Mutual Fund, Mutual Fund-SIP, Research reports, Insurance, etc. where the Member is just a distributor. These are not Exchange traded product and the Member is just acting as distributor. It should also state that all disputes with respect to the distribution activity, would not have access to Exchange investor redressal forum or Arbitration mechanism."      |      “The Stock Exchange, Mumbai is not in any manner answerable, responsible or liable to any person or persons for any acts of omission or commission, errors, mistakes and/or violation, actual or perceived, by us or our partners, agents, associates etc., of any of the Rules, Regulations, Bye-laws of the Stock Exchange, Mumbai, SEBI Act or any other laws in force from time to time. The Stock Exchange, Mumbai is not answerable, responsible or liable for any information on this Website or for any services rendered by our employees, our servants, and us. ”      |      "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account." .......... Issued in the interest of investors"
Company Name Logo

Address

B- 78, 3rd Floor, Defence Colony
New Delhi – 110 024

RISK DISCLOSURES ON DERIVATIVES

Attention Investors

  • Stock Brokers can accept securities as margin only by pledge.
  • Update your mobile number & email Id with your Stock Broker/Depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.
  • Pay 20% upfront margin of the transaction value to trade in cash market segment.
  • Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.
  • Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month

Precautions for clients dealing in Options

  • Do not Share your trading credentials – login id & passwords including OTP’s.
  • Do not Trade in leveraged products like options without proper understanding, which could lead to losses.
  • Do not Write/ sell options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Do not Deals in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, calls, etc.
  • Do not Trade in “Options” based on recommendations from unauthorised / unregistered investment advisors and influencers.

NSE SEBI CM INZ000017939 | NSE SEBI F&O INZ000017939 | BSE SEBI CM INZ000017939 | NSDL : IN-DP-443-2019 | CDSL: IN-DP-443-2019 | NCDEX SEBI INZ000017939 | MCX SEBI INZ000017939

@2023 Jyoti Broking Pvt. Ltd. All rights reserved

Designed, Developed, Maintained and Content Powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)